Project Grant R01CA300028
Award Date
8/1/25
Completion Date
7/31/30
Dollars Obligated
$656K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Colorado, USA
Similar Awards
This $656,014 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will fund a randomized clinical trial at The Ohio State University to evaluate the effectiveness of a telemedicine-mHealth symptom management intervention, called FOCUS, for advanced cancer patients in underserved rural communities. The FOCUS intervention aims to improve a symptom cluster including sleep difficulties, anxiety, depression, and fatigue, and enhance functional...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $979,000 to the Beckman Research Institute of the City of Hope to develop and test a blended e-health intervention for fear of progression (FOP) in patients with advanced gynecologic cancer. The 2-year project will adapt an existing FOP intervention for delivery via videoconferencing, self-study web modules, and nurse/social worker facilitation. This novel approach aims to increase access and...
This Project Grant award of $414,446 from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) will fund a 12-week group-based videoconference intervention to increase moderate to vigorous physical activity (MVPA) among cancer survivors. The study will randomize adult cancer survivors to the intervention or a comparator group, with the intervention including twice-weekly instructor-led aerobic/resistance exercise and PA behavior change sessions...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support a $1,338,648 hybrid effectiveness-implementation trial of the CARES intervention at the University of Pittsburgh. CARES is an integrated electronic health record-based screening and stepped collaborative care program designed to improve patient-centered outcomes for over 18 million Americans living with cancer who experience clinically significant levels of depression,...
This Project Grant award from the National Cancer Institute (CFDA Program 93.393 - Cancer Cause and Prevention Research) to Virginia Commonwealth University is providing $577,778 to investigate the feasibility and acceptability of the FEARLESS protocol, a novel mindfulness-based intervention targeting fear of cancer recurrence (FCR) in patients with primary malignant brain tumors and their caregivers. The study aims to address key information gaps related to recruitment methodology, study...
This Project Grant award of $621,732 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to evaluate a proactive identification and digital mental health intervention approach to address the unmet psychosocial needs of individuals living with likely incurable cancer. The key products or services to be delivered through this 5-year grant include: 1) Comprehensively assessing the effectiveness of a proactive identification method paired with...
This federal Project Grant award, totaling $696,140, was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The grant aims to test a digital psychoeducation-activation tool and implementation strategy, called ICAN DEPCARE, to improve uptake of evidence-based depression treatment among cancer patients. The project, led by The Trustees of Columbia University in the City of New York, will conduct a clinic-level cluster randomized...
This federal Project Grant award, valued at $746,926 and effective from July 9, 2024 to June 30, 2029, was issued by the National Cancer Institute (CFDA 93.353) under the 21st Century Cures Act - Beau Biden Cancer Moonshot program. The grant funds a multi-site randomized controlled trial to assess the efficacy of a phone-delivered Positive Psychological Intervention (PATH) for improving anxiety, depression, and quality of life in hematopoietic stem cell transplantation (HSCT) survivors. The...
The National Cancer Institute (NCI) awarded a $664,259 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Duke University. The grant is for the development and evaluation of the "AYA STEPS" digital health intervention, which aims to help adolescent and young adult (AYA) cancer survivors manage their symptoms and improve engagement with post-treatment care. The project involves a randomized controlled trial to assess the efficacy of the AYA STEPS...
This federal Project Grant award of $334,233, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support a comprehensive research study examining disparities in novel cancer therapies, the joint effects of cancer treatment and comorbidities, and multi-level contributors to cancer survival outcomes. The University of South Carolina, the prime awardee, will conduct innovative data linkages between the state cancer registry,...